Tue, 25 Nov 2014 14:33:19 GMT ~ ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 25, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and ...
Tue, 25 Nov 2014 14:00:00 GMT ~ ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervou
Thu, 13 Nov 2014 14:13:33 GMT ~ ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 13, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ...
Link: http://www.otcmarkets.com/stock/ACAD/company-info Ticker: $ACAD OTC Market Place: Not Available CIK code: 0001070494 Company name: ACADIA Pharmaceuticals, Inc. Company website: http://www.acadia-pharm.com Incorporated In: DE, USA
$ACAD share structure
## source: otcmarkets.com
Market Value: $3,039,003,338 a/o Dec 04, 2014 Shares Outstanding: 99,770,300 a/o Oct 31, 2014 Float: Not Available Authorized Shares: Not Available Par Value: 0.0001 $ACAD extra dd links
Company name: ACADIA Pharmaceuticals, Inc. Company website: http://www.acadia-pharm.com